Cargando…
Gender and immunosuppression impact on Merkel cell carcinoma diagnosis and prognosis. A population based cohort study
BACKGROUND: Merkel cell carcinoma (MCC), a rare cutaneous neuroendocrine endocrine tumour is increasing in incidence, and continues to carry a poor prognosis. OBJECTIVES: The objectives of this study were to examine all Irish cases of MCC from 1 January 1994 over 2 decades, focusing on gender and or...
Autores principales: | Keeling, E., O'Leary, E., Deady, S., O Neill, J. P., Conlon, P. J., Moloney, F. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060007/ https://www.ncbi.nlm.nih.gov/pubmed/35665203 http://dx.doi.org/10.1002/ski2.80 |
Ejemplares similares
-
Merkel Cell Carcinoma in Immunosuppressed Patients
por: Ma, Janice E., et al.
Publicado: (2014) -
The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients
por: Murray, Susan L., et al.
Publicado: (2020) -
Merkel cell carcinoma in an immunosuppressed patient
por: Góes, Heliana Freitas de Oliveira, et al.
Publicado: (2017) -
Large Intestinal Obstruction and Perforation From Metastatic Merkel Cell Carcinoma: A Case Report
por: Lee, David, et al.
Publicado: (2023) -
Unknown primary Merkel cell carcinoma in the immunosuppressed patient: Case series
por: Rizzo, Jason M., et al.
Publicado: (2020)